ABBV vs COST: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Costco Wholesale Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
Costco Wholesale Corporation · Consumer Defensive
$1,002.88
-35.4% upside to fair value
Grade C
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(+4.5%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
COST |
| Current Price |
$208.05 |
$1,002.88 |
| Fair Value Estimate |
$217.50 |
$648.03 |
| Upside to Fair Value |
+4.5%
|
-35.4%
|
| Market Cap |
$367.9B |
$444.9B |
| Forward P/E |
14.9x
|
52.1x
|
| EV / EBITDA |
16.7x
|
31.0x
|
| Price / Sales |
6.1x
|
1.6x
|
| Price / FCF |
20.9x
|
49.0x
|
| Revenue Growth YoY |
+8.6%
|
+3.4%
|
| Gross Margin |
83.7%
|
12.9%
|
| Operating Margin |
34.7%
|
3.8%
|
| Return on Equity |
-129.24%
|
28.8%
|
| Dividend Yield |
3.2% |
0% |
| FCF Yield |
4.78%
|
2.04%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
Costco Wholesale Corporation operates a global membership-based warehouse club model with over 900 warehouses across 14 countries, generating $254 billion in fiscal 2024 revenue. The company benefits from a durable competitive moat driven by scale advantages, a loyal membership base with high renewal rates, and superior employee retention through better wages and benefits. Despite steady revenue …
Accumulation Zones
| Metric |
ABBV |
COST |
| Zone Low |
$163.13 |
$486.02 |
| Zone High |
$184.88 |
$550.83 |
| In Buy Zone? |
No
|
No
|